If you think your current antidepressant isn’t helping, it probably isn’t.

Australia has one of the highest rates of depression worldwide, with 5.9% of the population--or over 1.3 million individuals—affected in 2022. Symptoms include loss of interest in activities, feelings of worthlessness and hopelessness, and insomnia.

If you’re between the ages of 18-65 and your antidepressant isn’t working well enough to alleviate your symptoms, know your options. Right now, local doctors are conducting research studies to evaluate add-on, investigational medication to take with (not instead of) your current antidepressant.

For yourself, for those you love, and for future generations, please consider volunteering for clinical trials. Join the fight against MDD. Together, we could help change lives.

Take the next step to see if you qualify for local research studies for people with Depression. But don’t delay — space is limited!

Get started now

How does it work?

1

Tell us a little bit about yourself

2

Answer some questions about your health

3

We will connect you to available studies in your area

Just takes a few minutes

Get started now

COVID-19 update — we remain open.

For the safety of both staff and patients, we require that our research sites are COVID-19 SMART facilities. That means they use best practices to reduce virus exposure and are dedicated to ensuring they remain open and available for the research of investigational medications.

COVID-19 SMART steps we are taking to ensure safety include:

  • Greatly increased availability of video office visits
  • Ensuring social distancing measures are taken in all waiting areas
  • Continuing the practice of cleaning and disinfecting exam rooms thoroughly between every patient visit
  • Appropriate personal protective equipment (PPE) for all staff members at our health clinics

AcurianHealth helps connect people with research studies that offer treatment under development. Since 1998, AcurianHealth has referred 1 million study candidates to 800 studies in 70 countries.